Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,729 evidence items · page 15 / 70

48.7 %48.7% of individuals felt ashamed or condemned because of their situation.

NigeriaVIH/sidapublished 2026Scientific reportsPubMeddocument of 6 observations

47.1 %47.1% of inmates in Bauchi Prison had good knowledge of HIV/AIDS.

NigeriaVIH/sidapublished 2023The Pan African medical journalPubMeddocument of 5 observations

Optic nerve sheath diameter values among HIV-positive patients on HAART are significantly higher among female subjects.

NigeriaVIH/sidaobserved October 2017 to June 2018published 2019Nigerian journal of clinical practicePubMeddocument of 5 observations

90.3 %In 2019, 90.3% of pregnant women receiving antenatal care in Nigeria were screened for HIV.

NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations

2,000,000 inhabitantsNigeria had nearly two million people living with HIV in 2021.

NigeriaVIH/sidaobserved 2021published 2023Frontiers in public healthPubMeddocument of 9 observations

56.2 %The seroprevalence of herpes simplex virus (HSV)-2 among patients with HIV in Nigeria was 56.2%.

Nigeriaherpes simplex virus (HSV)-2 · VIH/sidaobserved 2019published 2023BMJ openPubMeddocument of 5 observations

Sexual and gender minority people in Nigeria experience an HIV prevalence four to ten times higher than the national average.

NigeriaVIH/sidapublished 2026AIDS and behaviorPubMeddocument of 2 observations

56 %Some of the primary reasons for loss to follow-up were long distance to clinic (56%) and feeling healthy (6.7%).

NigeriaVIH/sidapublished 2019PloS onePubMeddocument of 8 observations

10 %Oral thrush was more prevalent in HAART-naïve patients (10%).

NigeriaVIH/sidapublished 2021Cardiovascular journal of AfricaPubMeddocument of 9 observations

28.8 %A weighted HIV prevalence of 28.8% was found among transgender populations in Nigeria.

NigeriaVIH/sidaobserved 2020published 2025Sexually transmitted infectionsPubMeddocument of 12 observations

4 %An impaired relaxation pattern was observed in 4.0% of the HIV group.

NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations

81 %Cross-resistance to at least one of the newer NNRTIs—doravirine, etravirine or rilpivirine—was predicted in 81% of participants with HIV-1 who had failed first-line ART in Nigeria.

NigeriaVIH/sidapublished 2022The Journal of antimicrobial chemotherapyPubMeddocument of 9 observations

68 %In a single-arm trial, self-reported adherence ≥90% among youth with HIV in Nigeria increased to 68% at 48 weeks (P = 0.031) compared with baseline.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

81.3 %Among 370 HIV-positive individuals in Akwa Ibom state, Nigeria, 81.3% were not virally suppressed in 2017.

NigeriaVIH/sidaobserved 2017published 2021Journal of the International AIDS SocietyPubMeddocument of 9 observations

7.2 %Forty-nine (7.2%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 had unknown HIV status.

NigeriaVIH/sidaobserved 2017 to 2021published 2024West African journal of medicinePubMeddocument of 14 observations

39.6 %Less than half of the participants strongly agreed that healthcare workers could provide post-exposure prophylaxis (PEP) to prevent human immunodeficiency virus (HIV) (39.6%).

NigeriaVIH/sidapublished 2025BMC women's healthPubMeddocument of 7 observations

28.5 %The rate of hearing loss among newly diagnosed HAART naive adult patients was 28.5%.

NigeriaVIH/sidaobserved July, 2018 to January, 2019published 2022Nigerian journal of clinical practicePubMeddocument of 5 observations

63.6 %The seroprevalence of herpes simplex virus (HSV)-2 was 63.6% among married patients with HIV in Nigeria.

Nigeriaherpes simplex virus (HSV)-2 · VIH/sidaobserved 2019published 2023BMJ openPubMeddocument of 5 observations

99.6 %CCSAPs achieved a viral load suppression rate of 99.6%.

NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations

Significant increases in alpha-1 and alpha-2 globulin concentrations were observed in the mono- and co-infected groups compared to the seronegative control group.

Nigeriahépatite B · VIH/sidapublished 2022African health sciencesPubMeddocument of 3 observations

22 USDThe unit cost per female sex worker tested for HIV was 22 USD.

NigeriaVIH/sidaobserved 2016published 2023PloS onePubMeddocument of 10 observations

1.5 %The proportion with HIV was 1.5% among participants with history of tattoo/body incision.

NigeriaVIH/sidapublished 2022Journal of immunoassay & immunochemistryeurope_pmcdocument of 5 observations

63 %The contribution from community-based modalities to children living with HIV identified increased from 63% to 84% during the implementation period.

NigeriaVIH/sidapublished 2023BMC pediatricsPubMeddocument of 10 observations

78 %Among women living with HIV during their perinatal period in Ibadan, Nigeria, 78.0% reported perceived stress.

NigeriaVIH/sidaobserved 2022published 2023Frontiers in public healthPubMeddocument of 3 observations

62 %The majority of participants (62%) were virally suppressed.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 8 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.